[
  {
    "ts": null,
    "headline": "FDA approves Incyte’s retifanlimab combo for SCAC treatment",
    "summary": "The regulator’s priority review and sBLA approval of the antibody were supported by data from Phase III and Phase II trials.",
    "url": "https://finnhub.io/api/news?id=17759f1d5e256164bc80d5597c27462d320d4e827d78ab517641cf9d8c7a2877",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747661194,
      "headline": "FDA approves Incyte’s retifanlimab combo for SCAC treatment",
      "id": 134602037,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "The regulator’s priority review and sBLA approval of the antibody were supported by data from Phase III and Phase II trials.",
      "url": "https://finnhub.io/api/news?id=17759f1d5e256164bc80d5597c27462d320d4e827d78ab517641cf9d8c7a2877"
    }
  }
]